Clinical Trial Update: MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on MMV390048's antimalarial activity against Plasmodium falciparum in healthy adult subjects in a Phase 1/2 study (Part B), w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MMV390048 (MMV390048)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED